ALXO — ALX Oncology Holdings Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-Broadcom, Crescent Energy Co, Gulfport Energy
ALX Oncology Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: ALX Oncology Q4 Basic EPS USD -0.93
Brief: Alx Oncology Holdings Says Co And Unit Entered Into Third Amendment To Loan And Security Agreement
Brief: ALX Oncology Q3 Basic EPS USD -1.24
ALX Oncology Holdings Inc expected to post a loss of 87 cents a share - Earnings Preview
Brief: ALX Oncology Announces Closing Of Public Offering, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares
ALX Oncology jumps as share offering priced at no discount
Brief: Alx Oncology Announces Pricing Of Public Offering
Brief: ALX Oncology Holdings Inc Had About $196.5 Million Of Cash, Cash Equivalents And Short-Term And Long-Term Investments As Of Sept 30, 2023
Brief: ALX Oncology Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-Anixa, Nano-X Imaging, Structure Therapeutics
U.S. STOCKS ON THE MOVE-Oddity Tech, Netflix, Warby Parker
ALX Oncology surges on positive mid-stage gastric cancer therapy trial data
Brief: Alx Oncology Holdings Inc - Jason Lettmann Appointed As Chief Executive Officer
U.S. RESEARCH ROUNDUP-Caci International, Cyberark Software, Ralph Lauren
ALX Oncology Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: ALX Oncology Q2 Basic EPS USD -0.84
ALX Oncology Holdings Inc expected to post a loss of 88 cents a share - Earnings Preview